Pancreatic Cancer Research

ResearcherAsan Medical CenterActive in the last 2 years

Seok‐Ho Kim

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2180-8442; OpenAlex author ID A5114400787. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. Advancing pancreatic cancer therapy by mesothelin-specific nanobody conjugation. Co-author DOI 10.1186/s12943-025-02325-7↗
  2. Pancreatic adenocarcinoma up-regulated factor (PAUF) enhances the accumulation and functional activity of myeloid-derived suppressor cells (MDSCs) in pancreati… Last author DOI 10.18632/oncotarget.10123↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Soyeon Yi · 1 shared paper, 2025 · strength 0.21
  2. Juyeon Jung · 1 shared paper, 2025 · strength 0.21
  3. Kyunghee Noh · 1 shared paper, 2025 · strength 0.21
  4. Jinhoi Song · 1 shared paper, 2016 · strength 0.05
  5. Sang Seok Koh · 1 shared paper, 2016 · strength 0.05
  6. Jae Min Lee · 1 shared paper, 2016 · strength 0.05
  7. Suhwan Chang · 1 shared paper, 2016 · strength 0.05
  8. Tae Heung Kang · 1 shared paper, 2016 · strength 0.05
  9. Yeon‐Jeong Kim · 1 shared paper, 2016 · strength 0.05
  10. Song Cheol Kim · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.